Skip to main content
SpringerLink
Log in

Molecular Biology of Gluco-Incretin Function

  • Chapter
Pancreatic Beta Cell in Health and Disease

  • 1568 Accesses

Abstract

The gluco-incretin hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon like peptide-1 (GLP-1) are secreted by intestinal endocrine cells and have been studied for many years because of their important effect to potentiate glucose-stimulated insulin secretion. In contrast to GIP, GLP-1 retains its insulinotropic effect in type 2 diabetic patients and a long-acting agonist of this peptide is now used for the treatment of this disease. Both peptides, however, have also long-term beneficial effect on the preservation or augmentation of the pancreatic beta-cell functional mass by stimulating beta-cell differentiation from precursors, proliferation of mature beta cells, and their protection against apoptosis. Although several studies have investigated the underlying molecular mechanisms, much remains to be learned about the mode of action of these hormones on beta cells. Here we review the current knowledge on gluco-incretin biology with a specific perspective on their beta-cell action. We also discuss the role that GLP-1 has on beta cells through indirect mechanisms, in particular through the regulation of the hepatoportal vein glucose sensors. This serves as a reminder that betacell function needs to be also studied in an integrated physiological approach where the complexity of their functional regulation can be appreciated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Holst JJ (2006) Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005. Diabetologia 49:253–260

    Article  PubMed  CAS  Google Scholar 

  2. Larsen PJ, Tang-Christansen M, Holst JJ, Orskov C (1997) Distribution of glucagonlike peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77:257–270

    Article  PubMed  CAS  Google Scholar 

  3. Bell GI, Santerre RF, Mullenbach GT (1983) Hamster preproglucagon contains the sequence of glucagon and two related peptides. Nature 302:716–718

    Article  PubMed  CAS  Google Scholar 

  4. Bell GI, Sanchez-Pescador R, Laybourn PJ, Najarian RC (1983) Exon duplication and divergence in the human preproglucagon gene. Nature 304:368–371

    Article  PubMed  CAS  Google Scholar 

  5. Zhu X, Zhou A, Dey A, Norrbom C, Carroll R, Zhang C, Laurent V, Lindberg I, Ugleholdt R, Holst JJ, Steiner DF (2002) Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects. Proc Natl Acad Sci USA 99:10293–10298

    Article  PubMed  CAS  Google Scholar 

  6. Rouille Y, Westermark G, Martin SK, Steiner DF (1994) Proglucagon is processed to glucagon by prohormone convertase PC2 in alpha TC1-6 cells. Proc Natl Acad Sci USA 91:3242–3246

    Article  PubMed  CAS  Google Scholar 

  7. Moody AJ, Thim L, Valverde I (1984) The isolation and sequencing of human gastric inhibitory peptide (GIP). FEBS Lett 172:142–148

    Article  PubMed  CAS  Google Scholar 

  8. Dube PE, Brubaker PL (2004) Nutrient, neural and endocrine control of glucagon-like peptide secretion. Horm Metab Res 36:755–760

    Article  PubMed  CAS  Google Scholar 

  9. Thorens B (1992) Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide I. Proc Natl Acad Sci USA 89:8641–8645

    Article  PubMed  CAS  Google Scholar 

  10. Thorens B, Porret A, Bühler L, Deng S-P, Morel P, Widmann C (1993) Cloning and functional expression of the human islet GLP-1 receptor. Demonstration that exendin-4 is an agonist and exendin-(9–39) an antagonist of the receptor. Diabetes 42:1678–1682

    Article  PubMed  CAS  Google Scholar 

  11. Lankat-Buttgereit B, Göke R, Fehmann HC, Richter G, Göke B (1994) Molecular cloning of a cDNA encoding for the GLP-1 receptor expressed in rat lung. Exp Clin Endocrinol 102:341–347

    Article  PubMed  CAS  Google Scholar 

  12. Mayo KE, Miller LJ, Bataille D, Dalle S, Göke B, Thorens B, Drucker DJ (2003) International Union of Pharmacology. XXXV. The glucagon receptor family. Pharmacol Rev 55:167–194

    Article  PubMed  CAS  Google Scholar 

  13. Göke R, Fehmann H-C, Linn T, Schmidt H, Krause M, Eng J, Göke B (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting β-cells. J Biol Chem 268:19650–19655

    PubMed  Google Scholar 

  14. Usdin TB, Mezey E, Button DC, Brownstein MJ, Bonner TI (1993) Gastric inhibitory polypeptide receptor, a member of the secretin-vasoactive intestinal peptide receptor family, is widely distributed in peripheral organs and the brain. Endocrinology 133:2861–2870

    Article  PubMed  CAS  Google Scholar 

  15. Gremlich S, Porret A, Hani E-H, Cherif D, Vionnet N, Froguel P, Thorens B (1995) Cloning, functional expression and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 44:1202–1208

    Article  PubMed  CAS  Google Scholar 

  16. Yamada Y, Hayami T, Nakamura K, Kaisaki PJ, Someya Y, Wang C-Z, Seino S, Seino Y (1995) Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. Genomics 29:773–776

    Article  PubMed  CAS  Google Scholar 

  17. Boylan MO, Jepeal LI, Wolfe MM (1999) Structure of the rat glucose-dependent insulinotropic polypeptide receptor. Peptides 20:219–228

    Article  PubMed  CAS  Google Scholar 

  18. Gelling RW, Coy DH, Pederson RA, Wheeler MB, Hinke S, Kwan T, McIntosch CH (1997) GIP(6-30)amide contains the high affinity binding region of GIP and is a potent inhibitor of GIP1-42 action in vitro. Regul Pept 69:151–154

    Article  PubMed  CAS  Google Scholar 

  19. Tseng CC, Kieffer TJ, Jarboe LA, Usdin TB, Wolfe MM (1996) Postprandial stimulation of insulin release by glucose-dependent insulinotropic polypeptide (GIP). Effect of a specific glucose-dependent insulinotropic polypeptide receptor antagonist in the rat. J Clin Invest 98:2440–2445

    Article  PubMed  CAS  Google Scholar 

  20. Widmann C, Bürki E, Dolci W, Thorens B (1994) Signal transduction by the cloned glucagon-like peptide-1 receptor. Comparison with signalling by the endogenous receptors of β cell lines. Mol Pharmacol 45:1029–1035

    PubMed  CAS  Google Scholar 

  21. Costes S, Broca C, Bertrand G, Lajoix AD, Bataille D, Bockaert J, Dalle S (2006) ERK1/2 control phosphorylation and protein level of cAMP-responsive element-binding protein: a key role in glucose-mediated pancreatic beta-cell survival. Diabetes 55:2220–2230

    Article  PubMed  CAS  Google Scholar 

  22. Gomez E, Pritchard C, Herbert TP (2002) cAMP-dependent protein kinase and Ca2+ influx through L-type voltage-gated calcium channels mediate raf-independent activation of extracellular regulated kinase in response to glucagon-like peptide-1 in pancreatic β-cells. J Biol Chem 277:48146–48151

    Article  PubMed  CAS  Google Scholar 

  23. Ehses JA, Pelech SL, Pederson RA, McIntosh CHS (2002) Glucose-dependent insulinotropic polypeptide activates the Raf-Mek1/2-ERK1/2 module via a cyclic AMP/cAMPdependent protein kinase/Rap1-mediated pathway. J Biol Chem 277:37088–37097

    Article  PubMed  CAS  Google Scholar 

  24. Arnette D, Gibson TB, Lawrence MC, January B, Khoo S, McGlynn K, Vanderbilt CA, Cobb MH (2003) Regulation of ERK1 and ERK2 by glucose and peptide hormones in pancreatic beta cells. J Biol Chem 278:32517–32525

    Article  PubMed  CAS  Google Scholar 

  25. Trumper J, Ross D, Jahr H, Brendel MD, Goke R, Horsch D (2005) The Rap-B-Raf signalling pathway is activated by glucose and glucagon-like peptide-1 in human islet cells. Diabetologia 48:1534–1540

    Article  PubMed  CAS  Google Scholar 

  26. Kerchner KR, Clay RL, McCleery G, Watson N, McIntire WE, Myung CS, Garrison JC (2004) Differential sensitivity of phosphatidylinositol 3-kinase p110gamma to isoforms of G protein betagamma dimers. J Biol Chem 279:44554–44562

    Article  PubMed  CAS  Google Scholar 

  27. Buteau J, Foisy S, Joly E, Prentki M (2003) Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52:124–132

    Article  PubMed  CAS  Google Scholar 

  28. Buteau J, Foisy S, Rhodes CJ, Carpenter L, Biden TJ, Prentki M (2001) Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes 50:2237–2243

    Article  PubMed  CAS  Google Scholar 

  29. Ebert R, Creutzfeldt W (1987) Gastrointestinal peptides and insulin secretion. Diabetes Metab Rev 3:1–26

    Article  PubMed  CAS  Google Scholar 

  30. Unger RH, Eisentraut AM (1969) Entero-insular axis. Arch Intern Med 123:261–266

    Article  PubMed  CAS  Google Scholar 

  31. Holst JJ, Orskov C, Vagn Nielsen O, Schwartz TW (1987) Truncated glucagon-like peptide 1, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169–174

    Article  PubMed  CAS  Google Scholar 

  32. Gromada J, Bokvist K, Ding WG, Holst JJ, Nielsen JH, Rorsman P (1998) Glucagon-like peptide 1 (7–36) amide stimulates exocytosis in human pancreatic beta-cells by both proximal and distal regulatory steps in stimulus-secretion coupling. Diabetes 47:57–65

    Article  PubMed  CAS  Google Scholar 

  33. Porksen N, Grofte B, Nyholm B, Holst JJ, Pincus SM, Veldhuis JD, Schmitz O, Butler PC (1998) Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion. Diabetes 47:45–49

    Article  PubMed  CAS  Google Scholar 

  34. Thorens B, Dériaz N, Bosco D, DeVos A, Pipeleers D, Schuit F, Meda P, Porret A (1996) Protein kinase A dependent phosphorylation of GLUT2 in pancreatic {beta} cells. J Biol Chem 271:8075–8081

    Article  PubMed  CAS  Google Scholar 

  35. Béguin P, Nagashima K, Nishimura M, Gonoi T, Seino S (1999) PKA-mediated phosphorylation of the human KATP channel: separate roles of Kir6.2 and SUR1 subunit phosphorylation. EMBO J 18:4722–4732

    Article  PubMed  Google Scholar 

  36. MacDonald PE, Wheeler MB (2003) Voltage-dependent K(+) channels in pancreatic beta cells: role, regulation and potential as therapeutic targets. Diabetologia 46:1046–1062

    Article  PubMed  CAS  Google Scholar 

  37. MacDonald PE, Wang X, Xia F, El-kholy W, Targonsky ED, Tsushima RG, Wheeler MB (2003) Antagonism of rat beta-cell voltage-dependent K+ currents by exendin 4 requires dual activation of the cAMP/protein kinase A and phosphatidylinositol 3-kinase signaling pathways. J Biol Chem 278:52446–52453

    Article  PubMed  CAS  Google Scholar 

  38. Ämmälä C, Ashcroft FM, Rorsman P (1993) Calcium-independent potentiation of insulin release by cyclic AMP in single {beta} cells. Nature 363:356–358

    Article  PubMed  Google Scholar 

  39. Ozaki N, Shibasaki T, Kashima Y, Miki T, Takahashi K, Ueno H, Sunaga Y, Yano M, Matsura Y, Iwanaga T, Takai Y, Seino S (2000) cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat Cell Biol 2:805–811

    Article  PubMed  CAS  Google Scholar 

  40. Woodford TA, Correll LA, McKnight GS, Corbin JD (1989) Expression and characterization of mutant forms of the type I regulatory subunit of cAMP-dependent protein kinase. The effect of defective cAMP binding on holoenzyme activation. J Biol Chem 264:13321–13328

    PubMed  CAS  Google Scholar 

  41. Holz GG, Leech CA, Heller RS, Castonguay M, Habener JF (1999) cAMP-dependent mobilization of intracellular Ca2+ stores by activation of ryanodine receptors in pancreatic β-cells. J Biol Chem 274:14147–14156

    Article  PubMed  CAS  Google Scholar 

  42. Zhou J, Wang X, Pineyro MA, Egan JM (1999) Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon-and insulin-producing cells. Diabetes 48:2358–2366

    Article  PubMed  CAS  Google Scholar 

  43. Zhou J, Pineyro MA, Wang X, Doyle ME, Egan JM (2002) Exendin-4 differentiation of a human pancreatic duct cell line into endocrine cells: involvement of PDX-1 and HNF3beta transcription factors. J Cell Physiol 192:304–314

    Article  PubMed  CAS  Google Scholar 

  44. Abraham EJ, Leech CA, Lin JC, Zulewski H, Habener JF (2002) Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells. Endocrinology 143:3152–3161

    Article  PubMed  CAS  Google Scholar 

  45. Hui H, Wright C, Perfetti R (2001) Glucagon-like peptide 1 induces differentiation of islet duodenal homeobox-1-positive pancreatic ductal cells into insulin-secreting cells. Diabetes 50:785–796

    Article  PubMed  CAS  Google Scholar 

  46. Kodama S, Toyonaga T, Kondo T, Matsumoto K, Tsuruzoe K, Kawashima J, Goto H, Kume K, Kume S, Sakakida M, Araki E (2005) Enhanced expression of PDX-1 and Ngn3 by exendin-4 during beta cell regeneration in STZ-treated mice. Biochem Biophys Res Commun 327:1170–1178

    Article  PubMed  CAS  Google Scholar 

  47. Xu G, Stoffers DA, Habener JF, Bonner-Weir S (1999) Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270–227

    Article  PubMed  CAS  Google Scholar 

  48. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM (2000) Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 49:741–748

    Article  PubMed  CAS  Google Scholar 

  49. Tourrel C, Bailbe D, Meile MJ, Kergoat M, Portha B (2001) Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50: 1562–1570

    Article  PubMed  CAS  Google Scholar 

  50. Tourrel C, Bailbe D, Lacorne M, Meile M-J, Kergoat M, Portha B (2002) Persistent improvement of type 2 diabetes in the Goto-Kakizaki rat model by expansion of the β-cell mass during the prediabetic period with glucagon-like peptide-1 or exendin-4. Diabetes 51:1443–1452

    Article  PubMed  CAS  Google Scholar 

  51. Stoffers DA, Desai BM, DeLeon DD, Simmons RA (2003) Neonatal exendin-4 prevents the development of diabetes in the intrauterine growth retarded rat. Diabetes 52: 734–740

    Article  PubMed  CAS  Google Scholar 

  52. Buteau J, Roduit R, Susini S, Prentki M (1999) Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42:856–864

    Article  PubMed  CAS  Google Scholar 

  53. Wang Q, Brubaker PL (2002) Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 45:1263–1273

    Article  PubMed  CAS  Google Scholar 

  54. Donath MY, Storling J, Maedler K, Mandrup-Poulsen T (2003) Inflammatory mediators and islet beta-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455–470

    Article  PubMed  CAS  Google Scholar 

  55. Mandrup-Poulsen T (1996) The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005–1029

    Article  PubMed  CAS  Google Scholar 

  56. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY (2002) Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851–860

    PubMed  CAS  Google Scholar 

  57. Ehses JA, Perren A, Eppler E, Ribaux P, Pospisilik JA, Maor-Cahn R, Gueripel X, Ellingsgaard H, Schneider MK, Biollaz G, Fontana A, Reinecke M, Homo-Delarche F, Donath MY (2007) Increased number of islet associated macrophages in type 2 diabetes. Diabetes: 56:2356–2370

    Article  PubMed  CAS  Google Scholar 

  58. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116:1802–1812

    Article  PubMed  CAS  Google Scholar 

  59. Scheuner D, Vander Mierde D, Song B, Flamez D, Creemers JW, Tsukamoto K, Ribick M, Schuit FC, Kaufman RJ (2005) Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nat Med 11:757–764

    Article  PubMed  CAS  Google Scholar 

  60. Wang J, Takeuchi T, Tanaka S, Kubo S-K, Kayo T, Lu D, Takata K, Koizumi A, Izumi T (1999) A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse. J Clin Invest 103:27–37

    Article  PubMed  CAS  Google Scholar 

  61. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ (2003) Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis. J Biol Chem 278:471–478

    Article  PubMed  CAS  Google Scholar 

  62. Li L, El-Kholy W, Rhodes CJ, Brubaker PL (2005) Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B. Diabetologia 48:1339–1349

    Article  PubMed  CAS  Google Scholar 

  63. Buteau J, El-Assaad W, Rhodes CJ, Rosenberg L, Joly E, Prentki M (2004) Glucagonlike peptide-1 prevents beta cell glucolipotoxicity. Diabetologia 47:806–815

    Article  PubMed  CAS  Google Scholar 

  64. Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, Pipeleers D, Ling Z, Drucker DJ (2006) GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metab 4:391–406

    Article  PubMed  CAS  Google Scholar 

  65. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R (2002) Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology 143:4397–4408

    Article  PubMed  CAS  Google Scholar 

  66. Hui H, Nourparvar A, Zhao X, Perfetti R (2003) Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5′-adenosine monophosphatedependent protein kinase A-and a phosphatidylinositol 3-kinase-dependent pathway. Endocrinology 144:1444–1455

    Article  PubMed  CAS  Google Scholar 

  67. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M, Montminy M (2003) cAMP promotes pancreatic beta-cells survival via CREB-mediated induction of IRS2. Gene Dev 17:1575–1580

    Article  PubMed  CAS  Google Scholar 

  68. Withers DJ, Sanchez Gutierrez J, Towery H, Burks DJ, Ren, J-M, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF (1998) Disruption of IRS-2 causes type 2 diabetes in mice. Nature 391:900–904

    Article  PubMed  CAS  Google Scholar 

  69. Park S, Dong X, Fisher TL, Dunn S, Omer AK, Weir G, White MF (2006) Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. J Biol Chem 281:1159–1168

    Article  PubMed  CAS  Google Scholar 

  70. Inada A, Hamamoto Y, Tsuura Y, Miyazaki J, Toyokuni S, Ihara Y, Nagai K, Yamada Y, Bonner-Weir S, Seino Y (2004) Overexpression of inducible cyclic AMP early repressor inhibits transactivation of genes and cell proliferation in pancreatic beta cells. Mol Cell Biol 24:2831–2841

    Article  PubMed  CAS  Google Scholar 

  71. Li Y, Cao X, Li LX, Brubaker PL, Edlund H, Drucker DJ (2005) beta-Cell Pdx1 expression is essential for the glucoregulatory, proliferative, and cytoprotective actions of glucagon-like peptide-1. Diabetes 54:482–491

    Article  PubMed  CAS  Google Scholar 

  72. Buteau J, Spatz ML, Accili D (2006) Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes 55:1190–1196

    Article  PubMed  CAS  Google Scholar 

  73. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH, Wright CVE, White MF, Arden KC, Accili D (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth. J Clin Invest 110:1839–1847

    PubMed  CAS  Google Scholar 

  74. Scrocchi LA, Brown TJ, MacLusky N, Brubaker PL, Auerbach AB, Joyner AL, Drucker DJ (1996) Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide-1 receptor gene. Nat Med 2:1254–1258

    Article  PubMed  CAS  Google Scholar 

  75. Miyawaki K, Yamada Y, Yano H, Niwa H, Ban N, Ihara Y, Kubota A, Fujimoto S, Kajikawa M, Kuroe A, Tsuda K, Hashimoto H, Yamashita T, Jomori T, Tashiro F, Miyazaki J-I, Seino Y (1999) Glucose intolerance caused by a defect in the enteroinsular axis: a study in gastric inhibitory polypeptide receptor knockout mice. Proc Natl Acad Sci USA 96:14843–14847

    Article  PubMed  CAS  Google Scholar 

  76. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T, Seino Y (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat Med 8:738–742

    Article  PubMed  CAS  Google Scholar 

  77. Preitner F, Ibberson M, Franklin I, Binnert C, Pende M, Gjinovici A, Hansotia T, Drucker DJ, Wollheim CB, Burcelin R, Thorens B (2004) Gluco-incretin control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 113:635–645

    PubMed  CAS  Google Scholar 

  78. Hansotia T, Baggio LL, Delmeire D, Hinke SA, Yamada Y, Tsukiyama K, Seino Y, Holst JJ, Schuit F, Drucker DJ (2004) Double incretin receptor knockout (DIRKO) mice reveal an essential role for the enteroinsular axis in transducing the glucoregulatory actions of DPP-IV inhibitors. Diabetes 53:1326–1335

    Article  PubMed  CAS  Google Scholar 

  79. Rolin B, Larsen MO, Gotfredsen CF, Deacon CF, Carr RD, Wilken M, Knudsen LB (2002) The long-acting GLP-1 derivative NN2211 ameliorates glycemia and increases beta-cell mass in diabetic mice. Am J Physiol Endocrinol Metab 283:E745–E752

    PubMed  CAS  Google Scholar 

  80. Egan JM, Bulotta A, Hui H, Perfetti R (2003) GLP-1 receptor agonists are growth and differentiation factors for pancreatic islet beta cells. Diabetes Metab Res Rev 19:115–123

    Article  PubMed  CAS  Google Scholar 

  81. Movassat J, Beattie GM, Lopez AD, Hayek A (2002) Exendin 4 up-regulates expression of PDX 1 and hastens differentiation and maturation of human fetal pancreatic cells. J Clin Endocrinol Metab 87:4775–4781

    Article  PubMed  CAS  Google Scholar 

  82. De Leon DD, Deng S, Madani R, Ahima RS, Drucker DJ, Stoffers DA (2003) Role of endogenous glucagon-like peptide-1 in islet regeneration after partial pancreatectomy. Diabetes 52:365–371

    Article  PubMed  Google Scholar 

  83. Burcelin R, Crivelli V, Perrin C, Da Costa A, Mu J, Kahn BB, Birnbaum MJ, Kahn CR, Vollenweider P, Thorens B (2003) GLUT4, AMP kinase, but not the insulin receptor, are required for hepatoportal glucose sensor-stimulated muscle glucose utilization. J Clin Invest 111:1555–1562

    PubMed  CAS  Google Scholar 

  84. Thorens B (2004) The hepatoportal glucose sensor. Mechanisms of glucose sensing and signal transduction. In: Matschinski FM, Magnuson MA (eds) Glucokinase and glycemic disease: from basics to novel therapeutics. Karger, Basel, pp 327–338

    Chapter  Google Scholar 

  85. Niijima A (1969) Afferent impulse discharges from glucoreceptors in the liver of the guinea pig. Ann N Y Acad Sci 157:690–700

    Article  PubMed  CAS  Google Scholar 

  86. Niijima A (1982) Glucose-sensitive afferent nerve fibres in the hepatic branch of the vagus nerve in the guinea-pig. J Physiol 332:315–323

    PubMed  CAS  Google Scholar 

  87. Nakabayashi H, Nishizawa M, Nakagawa A, Takeda R, Niijima A (1996) Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 271:E808–E813

    PubMed  CAS  Google Scholar 

  88. Nishizawa M, Nakabayashi H, Uchida K, Nakagawa A, Niijima A (1996) The hepatic vagal nerve is receptive to incretin hormone glucagon-like peptide-1, but not to glucose-dependent insulinotropic polypeptide, in the portal vein. J Auton Nerv Syst 61:149–154

    Article  PubMed  CAS  Google Scholar 

  89. Balkan B, Li X (2000) Portal GLP-1 administration in rats augments the insulin response to glucose via neuronal mechanisms. Am J Physiol Regul Integr Comp Physiol 279:R1449–R1454

    PubMed  CAS  Google Scholar 

  90. Burcelin R, DaCosta A, Drucker D, Thorens B (2001) Glucose competence of the hepatoporal vein sensor requires the presence of an activated GLP-1 receptor. Diabetes 50:1720–1728

    Article  PubMed  CAS  Google Scholar 

  91. Flamez D, Van Breusegem A, Scrocchi LA, Quartier E, Pipeleers D, Drucker DJ, Schuit F (1998) Mouse pancreatic β-cells exhibit preserved glucose competence after disruption of the glucagon-like peptide-1 receptor gene. Diabetes 47: 646–652

    Article  PubMed  CAS  Google Scholar 

  92. Ahren B (2004) Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice. Am J Physiol Regul Integr Comp Physiol 286:R269–R272

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physiology and Center for Integrative Genomics, University of Lausanne, Genopode Building, Lausanne, Switzerland

    Sonia Klinger & Bernard Thorens

Authors
  1. Sonia Klinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bernard Thorens
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Division of Cellular and Molecular Medicine, Department of Physiology and Cell Biology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe, 650-0017, Japan

    Susumu Seino M.D., D.M. Sci. (Professor) (Professor)

  2. Medicine and Human Genetics, The University of Chicago, 5841 South Maryland Avenue, Chicago, IL, 60637, USA

    Graeme I. Bell Ph.D. (Louis Block Distinguished Service Professor) (Louis Block Distinguished Service Professor)

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer

About this chapter

Cite this chapter

Klinger, S., Thorens, B. (2008). Molecular Biology of Gluco-Incretin Function. In: Seino, S., Bell, G.I. (eds) Pancreatic Beta Cell in Health and Disease. Springer, Tokyo. https://doi.org/10.1007/978-4-431-75452-7_16

Download citation

Publish with us

Policies and ethics

Search

Navigation